Related Experiment Video
Updated: Jan 28, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Jehoshua Sharma1, Sierra Rosiana2, Iqra Razzaq3
1Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada. jehoshua@uoguelph.ca.
Abstract:
Fungal infections are a growing public health concern, and an increasingly important cause of human mortality, with Candida species being amongst the most frequently encountered of these opportunistic fungal pathogens. Several Candida species are polymorphic, and able to transition between distinct morphological states, including yeast, hyphal, and pseudohyphal forms. While not all Candida pathogens are polymorphic, the ability to undergo morphogenesis is linked with the virulence of many of these pathogens. There are also many connections between Candida morphogenesis and antifungal drug treatment and susceptibility. Here, we review how Candida morphogenesis-a key virulence trait-is linked with antifungal drugs and antifungal drug resistance. We highlight how antifungal therapeutics are able to modulate morphogenesis in both sensitive and drug-resistant Candida strains, the shared signaling pathways that mediate both morphogenesis and the cellular response to antifungal drugs and drug resistance, and the connection between Candida morphology, drug resistance, and biofilm growth. We further review the development of anti-virulence drugs, and targeting Candida morphogenesis as a novel therapeutic strategy to target fungal pathogens. Together, this review highlights important connections between fungal morphogenesis, virulence, and susceptibility to antifungals.
Insights
Candida morphogenesis, its link to virulence, and antifungal drug resistance are reviewed. Targeting this fungal trait offers a novel therapeutic strategy against opportunistic fungal infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Drug Discovery
Background:
- Fungal infections, particularly by *Candida* species, are a significant cause of mortality.
- Morphogenesis (shape-shifting) in *Candida* is a key virulence factor linked to disease severity.
- Understanding morphogenesis is crucial for developing effective antifungal treatments.
Purpose of the Study:
- To review the intricate relationship between *Candida* morphogenesis and antifungal drug resistance.
- To explore how antifungal drugs influence fungal morphology in both susceptible and resistant strains.
- To discuss targeting morphogenesis as a novel anti-virulence strategy.
Main Methods:
- Literature review of studies on *Candida* morphogenesis, virulence, and antifungal drug interactions.
- Analysis of shared signaling pathways mediating morphogenesis and drug response.
- Examination of the link between morphology, drug resistance, and biofilm formation.
Main Results:
- Antifungal therapeutics can modulate *Candida* morphogenesis, impacting drug susceptibility.
- Shared signaling pathways connect morphogenesis, drug response, and resistance mechanisms.
- *Candida* morphology is closely associated with drug resistance and biofilm development.
Conclusions:
- *Candida* morphogenesis is a critical virulence trait intertwined with antifungal drug resistance.
- Targeting fungal morphogenesis presents a promising avenue for novel anti-virulence therapies.
- Further research into these connections can lead to improved treatment strategies for fungal infections.
More Related Videos
Related Concept Videos
Morphogenesis
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
X-linked Traits
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Susceptibility, Permittivity and Dielectric Constant

